The specter of generic rivalry has long loomed above copyright’s famous drug, Viagra, triggering questions about the prospects of similar drug holdings. While initial periods saw substantial profits, the intellectual property lapse has allowed the door for discounted alternatives, likely diminishing revenue and creating a significant risk for st… Read More